Cargando…

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer

Immunotherapy based on checkpoint blockers has proven survival benefits in patients with melanoma and other malignancies. Nevertheless, a significant proportion of treated patients remains refractory, suggesting that in combination with active immunizations, such as cancer vaccines, they could be he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rojas-Sepúlveda, Daniel, Tittarelli, Andrés, Gleisner, María Alejandra, Ávalos, Ignacio, Pereda, Cristián, Gallegos, Iván, González, Fermín Eduardo, López, Mercedes Natalia, Butte, Jean Michel, Roa, Juan Carlos, Fluxá, Paula, Salazar-Onfray, Flavio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Focussed Research Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244977/ https://www.ncbi.nlm.nih.gov/pubmed/29600445 http://dx.doi.org/10.1007/s00262-018-2157-5

Ejemplares similares

A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth
por: Gleisner, María Alejandra, et al.
Publicado: (2020)

High CD8(+) and absence of Foxp3(+) T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival
por: Fluxá, Paula, et al.
Publicado: (2018)

Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy
por: González, Fermín E., et al.
Publicado: (2018)

Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses In Vitro
por: Flores, Iván, et al.
Publicado: (2019)

The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder-Cancer Patients
por: Carrasco, Cristian, et al.
Publicado: (2021)

Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival
por: Tittarelli, Andrés, et al.
Publicado: (2023)

Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections
por: Gleisner, María Alejandra, et al.
Publicado: (2017)

Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy
por: García-Salum, Tamara, et al.
Publicado: (2018)

Connexin-Mediated Signaling at the Immunological Synapse
por: Tittarelli, Andrés, et al.
Publicado: (2020)

Cx43-Gap Junctions Accumulate at the Cytotoxic Immunological Synapse Enabling Cytotoxic T Lymphocyte Melanoma Cell Killing
por: Hofmann, Francisca, et al.
Publicado: (2019)

Haptoglobin Induces a Specific Proteomic Profile and a Mature-Associated Phenotype on Primary Human Monocyte-Derived Dendritic Cells
por: Torres, Alfredo, et al.
Publicado: (2022)

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

Immune biological rationales for the design of combined radio- and immunotherapies
por: Hader, Michael, et al.
Publicado: (2020)

4-1BB agonism: adding the accelerator to cancer immunotherapy
por: Chester, Cariad, et al.
Publicado: (2016)

Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
por: Venuti, Aldo, et al.
Publicado: (2015)

Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges
por: Srivastava, Pramod K., et al.
Publicado: (2013)

A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens
por: Seidel, Ursula J. E., et al.
Publicado: (2011)

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
por: Andersen, Mads Hald
Publicado: (2012)

MHC-based detection of antigen-specific CD8(+) T cell responses
por: Hadrup, Sine Reker, et al.
Publicado: (2010)

Modeling flow cytometry data for cancer vaccine immune monitoring
por: Frelinger, Jacob, et al.
Publicado: (2010)

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge
por: de Witte, Moniek A., et al.
Publicado: (2015)

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
por: Sersa, Gregor, et al.
Publicado: (2015)

Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies
por: van den Bijgaart, Renske J. E., et al.
Publicado: (2016)

How frequently are predicted peptides actually recognized by CD8 cells?
por: Moldovan, Ioana, et al.
Publicado: (2016)

Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands
por: Raaijmakers, Tonke K., et al.
Publicado: (2018)

Exercise and cancer: from “healthy” to “therapeutic”?
por: Idorn, Manja, et al.
Publicado: (2017)

Evolution of MHC-based technologies used for detection of antigen-responsive T cells
por: Bentzen, Amalie Kai, et al.
Publicado: (2017)

Unlocking the therapeutic potential of primary tumor-draining lymph nodes
por: Rotman, Jossie, et al.
Publicado: (2019)

Conventional CARs versus modular CARs
por: Feldmann, Anja, et al.
Publicado: (2019)

Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation
por: Bialek-Waldmann, Julia K., et al.
Publicado: (2019)

Lysyl oxidases: linking structures and immunity in the tumor microenvironment
por: Tenti, Paolo, et al.
Publicado: (2019)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Long-term surviving cancer patients as a source of therapeutic TCR
por: Inderberg, Else Marit, et al.
Publicado: (2020)

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia
por: Jordaens, Stephanie, et al.
Publicado: (2020)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
por: Lopez, Ernesto, et al.
Publicado: (2023)

Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity
por: Tittarelli, A, et al.
Publicado: (2015)

Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity
por: Tittarelli, A, et al.
Publicado: (2016)

Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients
por: Reyes, D, et al.
Publicado: (2013)

Mechanical ventilation of mice
por: Schwarte, L.A., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_ev9frh8225fcfglh3g58tbojgc